Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor–neutralizing therapy in patients with inflammatory bowel disease

Authors: Oxford IBD Cohort Investigators, Nathaniel R. West, Ahmed N. Hegazy, Benjamin M. J. Owens, Samuel J. Bullers, Bryan Linggi, Sofia Buonocore, Margherita Coccia, Dieter Görtz, Sébastien This, Krista Stockenhuber, Johanna Pott, Matthias Friedrich, Grigory Ryzhakov, Frédéric Baribaud, Carrie Brodmerkel, Constanze Cieluch, Nahid Rahman, Gerhard Müller‐Newen, Raymond J. Owens, Anja A. Kühl, Kevin J. Maloy, Scott E. Plevy, Satish Keshav, Simon Travis, Fiona Powrie - Nature Medicine 2017 cited by 805